Esperion Therapeutics
ESPR
#6408
Rank
HK$6.20 B
Marketcap
HK$25.96
Share price
-4.60%
Change (1 day)
83.58%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: HK$6.20 Billion

As of February 2026 Esperion Therapeutics has a market cap of HK$6.20 Billion. This makes Esperion Therapeutics the world's 6408th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$6.20 B-16.72%
2025HK$7.45 B113.67%
2024HK$3.48 B31.34%
2023HK$2.65 B-25.96%
2022HK$3.58 B51.06%
2021HK$2.37 B-54.55%
2020HK$5.22 B-59.1%
2019HK$12.77 B32.16%
2018HK$9.66 B-28.3%
2017HK$13.47 B515.44%
2016HK$2.18 B-43.63%
2015HK$3.88 B-39.12%
2014HK$6.38 B290.41%
2013HK$1.63 B

End of Day market cap according to different sources

On Feb 22nd, 2026 the market cap of Esperion Therapeutics was reported to be:

HK$6.50 Billion
by Nasdaq info icon info icon
HK$6.50 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
HK$1.202 T 19,279.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$646.71 B 10,320.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
HK$17.40 B 180.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
HK$4.85 B-21.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$35.18 B 466.98%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$96.91 B 1,461.72%๐Ÿ‡บ๐Ÿ‡ธ USA